Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · May 07, 2022

Digital Breast Tomosynthesis Plus Synthesised Mammography vs Digital Screening Mammography for the Detection of Invasive Breast Cancer

The Lancet Oncology


Additional Info

The Lancet Oncology
Digital breast tomosynthesis plus synthesised mammography versus digital screening mammography for the detection of invasive breast cancer (TOSYMA): a multicentre, open-label, randomised, controlled, superiority trial
Lancet Oncol 2022 Apr 12;[EPub Ahead of Print], W Heindel, S Weigel, J Gerß, HW Hense, A Sommer, M Krischke, L Kerschke

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading